Valencia Technologies, a Valencia, CA-based neuromodulation firm targeted on minimally invasive remedy of urinary incontinence, introduced a strategic funding of as much as $35M of dedicated capital and the appointment of James D. Surek as CEO.
The spherical was funded by Brooks Advisory Group, an affiliate of Brooks Administration Group.
The corporate intends to make use of the funds to speed up the expansion of its flagship product, the eCoin® system.
Valencia Applied sciences is a medical system firm that manufactures and markets the eCoin system, a subcutaneous implantable tibial nerve stimulator for UUI. Valencia Applied sciences obtained FDA approval for the eCoin system in 2022.
FinSMEs
24/02/2025
